Mona Khalaj
Affiliations: | 2011-2017 | Memorial Sloan Kettering Cancer Center, Rockville Centre, NY, United States | |
| 2018- | SCBRM | Stanford University School of Medicine, Palo Alto, CA, United States |
Website:
https://profiles.stanford.edu/mona-khalajGoogle:
"Mona Khalaj"Bio:
https://www.researchgate.net/profile/Mona_Khalaj
https://events.weill.cornell.edu/event/microrna_regulation_of_self_renewal_in_normal_and_malignant_hematopoietic_stem_cells#.XuHTS25uLDc
Parents
Sign in to add mentor| Christopher Y Park | grad student | 2011-2017 | Memorial Sloan Kettering Cancer Center (Neurotree) | |
| (MicroRNA Regulation of Self Renewal in Normal and Malignant Hematopoietic Stem Cells) | ||||
| Irving L. Weissman | post-doc | 2018- | Stanford Medical School | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Stranahan AW, Berezniuk I, Chakraborty S, et al. (2022) Leukotrienes promote stem cell self-renewal and chemoresistance in acute myeloid leukemia. Leukemia |
| Rassouli H, Khalaj M, Hassani SN, et al. (2019) Gene Expression Patterns of Royan Human Embryonic Stem Cells Correlate with Their Propensity and Culture Systems. Cell Journal. 21: 290-299 |
| Amin S, Cook B, Zhou T, et al. (2018) Discovery of a drug candidate for GLIS3-associated diabetes. Nature Communications. 9: 2681 |
| Khalaj M, Woolthuis CM, Hu W, et al. (2017) miR-99 regulates normal and malignant hematopoietic stem cell self-renewal. The Journal of Experimental Medicine |
| Khalaj M, Park CY. (2017) snoRNAs contribute to myeloid leukaemogenesis. Nature Cell Biology. 19: 758-760 |
| Chung SS, Eng WS, Hu W, et al. (2017) CD99 is a therapeutic target on disease stem cells in myeloid malignancies. Science Translational Medicine. 9 |
| Elias HK, Khalaj M, Park CY. (2016) Divergent roles of in normal and malignant stem cells. Translational Cancer Research. 5: S328-S331 |
| Elias HK, Khalaj M, Park CY. (2016) Divergent roles of miR-126 in normal and malignant stem cells Translational Cancer Research. 5 |
| Khalaj M, Woolthuis C, Hu W, et al. (2016) Mir-99 Regulates Normal and Leukemic Stem Cell Function Blood. 128: 1469-1469 |
| Khalaj M, Hu W, Park CY. (2015) Mir-99 Is a Regulator of Hematopoietic and Leukemic Stem Cell Differentiation Blood. 126: 3063-3063 |